PortfoliosLab logoPortfoliosLab logo
PZG vs. AYTU
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

PZG vs. AYTU - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Paramount Gold Nevada Corp. (PZG) and Aytu BioPharma, Inc. (AYTU). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, PZG achieves a -7.14% return, which is significantly higher than AYTU's -11.92% return.


PZG

1D
-1.68%
1M
-18.75%
YTD
-7.14%
6M
1.74%
1Y
103.90%
3Y*
59.19%
5Y*
2.58%
10Y*
-3.20%

AYTU

1D
1.78%
1M
-8.40%
YTD
-11.92%
6M
2.23%
1Y
14.50%
3Y*
12.70%
5Y*
-53.73%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

PZG vs. AYTU - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
PZG
Paramount Gold Nevada Corp.
-7.14%268.42%-8.80%8.70%-50.62%-40.29%51.28%-6.82%-36.15%-26.97%
AYTU
Aytu BioPharma, Inc.
-11.92%52.94%-40.14%-24.87%-86.00%-77.42%-38.35%22.41%-98.22%-88.85%

Correlation

The correlation between PZG and AYTU is 0.11, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.11

Correlation (3Y)
Calculated over the trailing 3-year period

0.07

Correlation (5Y)
Calculated over the trailing 5-year period

0.12

Correlation (All Time)
Calculated using the full available price history since Feb 2, 2017

0.09

Fundamentals

Market Cap

PZG:

$97.27M

AYTU:

$24.07M

EPS

PZG:

-$0.09

AYTU:

-$2.91

PB Ratio

PZG:

2.75

AYTU:

0.68

Total Revenue (TTM)

PZG:

$0.00

AYTU:

$56.60M

Gross Profit (TTM)

PZG:

-$892.14K

AYTU:

$36.14M

EBITDA (TTM)

PZG:

-$11.01M

AYTU:

-$27.34M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

PZG vs. AYTU — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PZG
PZG Risk / Return Rank: 7777
Overall Rank
PZG Sharpe Ratio Rank: 8282
Sharpe Ratio Rank
PZG Sortino Ratio Rank: 8080
Sortino Ratio Rank
PZG Omega Ratio Rank: 7676
Omega Ratio Rank
PZG Calmar Ratio Rank: 7474
Calmar Ratio Rank
PZG Martin Ratio Rank: 7575
Martin Ratio Rank

AYTU
AYTU Risk / Return Rank: 5151
Overall Rank
AYTU Sharpe Ratio Rank: 5252
Sharpe Ratio Rank
AYTU Sortino Ratio Rank: 4949
Sortino Ratio Rank
AYTU Omega Ratio Rank: 4949
Omega Ratio Rank
AYTU Calmar Ratio Rank: 5252
Calmar Ratio Rank
AYTU Martin Ratio Rank: 5353
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

PZG vs. AYTU - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Paramount Gold Nevada Corp. (PZG) and Aytu BioPharma, Inc. (AYTU). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


PZGAYTUDifference
Sharpe ratioReturn per unit of total volatility

+1.17

Sortino ratioReturn per unit of downside risk

+1.48

Omega ratioGain probability vs. loss probability

1.26

1.10

+0.16

Calmar ratioReturn relative to maximum drawdown

1.86

0.41

+1.45

Martin ratioReturn relative to average drawdown

4.65

0.97

+3.67

PZG vs. AYTU - Sharpe Ratio Comparison

The current PZG Sharpe Ratio is 1.44, which is higher than the AYTU Sharpe Ratio of 0.27. The chart below compares the historical Sharpe Ratios of PZG and AYTU, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


PZGAYTUDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.44

0.27

+1.17

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.04

-0.63

+0.67

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

-0.05

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.09

-0.36

+0.27

Drawdowns

PZG vs. AYTU - Drawdown Comparison

The maximum PZG drawdown since its inception was -93.81%, smaller than the maximum AYTU drawdown of -100.00%. Use the drawdown chart below to compare losses from any high point for PZG and AYTU.


Loading charts...

Drawdown Indicators


PZGAYTUDifference

Max Drawdown

Largest peak-to-trough decline

-93.81%

-100.00%

+6.19%

Max Drawdown (1Y)

Largest decline over 1 year

-56.18%

-35.47%

-20.71%

Max Drawdown (3Y)

Largest decline over 3 years

-56.18%

-70.24%

+14.06%

Max Drawdown (5Y)

Largest decline over 5 years

-74.05%

-99.12%

+25.07%

Max Drawdown (10Y)

Largest decline over 10 years

-90.14%

Current Drawdown

Current decline from peak

-73.53%

-100.00%

+26.47%

Average Drawdown

Average peak-to-trough decline

-68.57%

-95.15%

+26.58%

Ulcer Index

Depth and duration of drawdowns from previous peaks

22.43%

14.92%

+7.51%

Volatility

PZG vs. AYTU - Volatility Comparison

Paramount Gold Nevada Corp. (PZG) has a higher volatility of 19.29% compared to Aytu BioPharma, Inc. (AYTU) at 14.09%. This indicates that PZG's price experiences larger fluctuations and is considered to be riskier than AYTU based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


PZGAYTUDifference

Volatility (1M)

Calculated over the trailing 1-month period

19.29%

14.09%

+5.20%

Volatility (6M)

Calculated over the trailing 6-month period

58.36%

33.39%

+24.97%

Volatility (1Y)

Calculated over the trailing 1-year period

72.88%

55.06%

+17.82%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

62.90%

85.66%

-22.76%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

60.72%

188.20%

-127.48%

Dividends

PZG vs. AYTU - Dividend Comparison

Neither PZG nor AYTU has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

PZG vs. AYTU - Financials Comparison

This section allows you to compare key financial metrics between Paramount Gold Nevada Corp. and Aytu BioPharma, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00M10.00M15.00M20.00M25.00M30.00M35.00M202220232024202520260
12.41M
(PZG) Total Revenue
(AYTU) Total Revenue
Values in USD except per share items

Frequently Asked Questions


PZG and AYTU have a correlation of 0.11, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

PZG has higher volatility (19.29%) compared to AYTU (14.09%). In terms of maximum drawdown, PZG dropped -93.81% vs AYTU's -100.00%.

PZG currently has the higher Sharpe Ratio (1.44 vs 0.27), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for PZG and AYTU

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer